M
Matthew B. Grisham
Researcher at Texas Tech University Health Sciences Center
Publications - 351
Citations - 30238
Matthew B. Grisham is an academic researcher from Texas Tech University Health Sciences Center. The author has contributed to research in topics: Nitric oxide & Colitis. The author has an hindex of 92, co-authored 349 publications receiving 29002 citations. Previous affiliations of Matthew B. Grisham include University Medical Center New Orleans & LSU Health Sciences Center New Orleans.
Papers
More filters
Book ChapterDOI
Detection of s-nitrosothiols by fluorometric and colorimetric methods
David A. Wink,Sungmee Kim,Deborah Coffin,John C. Cook,Yoram Vodovotz,Danae Chistodoulou,David Jourd'heuil,Matthew B. Grisham +7 more
TL;DR: The colorimetric reaction described herein utilizes the chemistry that occurs among nitrosating species such as those in the NO/O2 reaction and sulfanilamide (SULF) to form a diazonium ion to yield a primary nitrosamine that is converted rapidly to a fluorescent triazole.
Journal ArticleDOI
CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon.
Thorsten Vowinkel,Christoph Anthoni,Katherine C. Wood,Karen Y. Stokes,Janice Russell,Laura Gray,Sulaiman Bharwani,Norbert Senninger,J. Steven Alexander,Christian F. Krieglstein,Matthew B. Grisham,D. Neil Granger +11 more
TL;DR: Findings implicate CD40-CD40L in the pathogenesis of DSS-induced intestinal inflammation, and suggest that modulation of leukocyte and platelet recruitment by activated, CD 40-positive endothelial cells in colonic venules may represent a major action of this signaling pathway.
Journal ArticleDOI
Pharmacological Intervention Studies Using Mouse Models of the Inflammatory Bowel Diseases: Translating Preclinical Data into New Drug Therapies
TL;DR: A critical evaluation of the different mouse models and pharmacological approaches that may be used in intervention studies as well as discuss emerging issues related to study design and data interpretation of preclinical studies are presented.
Journal ArticleDOI
Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 integrins
Maisoun Abdelbaqi,John H. Chidlow,Kametra M. Matthews,Kevin P. Pavlick,Shayne C. Barlow,Andrea J. Linscott,Matthew B. Grisham,Marjorie R. Fowler,Christopher G. Kevil +8 more
TL;DR: It is demonstrated that genetic loss of CD18 or CD11a is protective during experimental colitis and that CD11b may serve a regulatory role during development of disease.
Journal ArticleDOI
Nitro containing L-arginine analogs interfere with assays for nitrate and nitrite.
Stan S. Greenberg,Jianming Xie,John J. Spitzer,Ji-fang Wang,Jack R. Lancaster,Matthew B. Grisham,David R. Powers,Thomas D. Giles +7 more
TL;DR: It is concluded that in vivo and in vitro use of LNAME and LNA and in vivo use of high doses of aminoguanidine interfere with the assay of NO2- and NO3- with the modified Griess reaction and with chemiluminescence.